With Trump’s avowed interest in seeing the cost of prescriptions cut, a Democratic laser focus on the issue could actually bring about legislation to bring down drug prices. (Photo: Shutterstock)

Democratic gains in the midterms could finally bring action on drug pricing—and the pharmaceutical industry is worried.

While there’s still the chance of gridlock, thanks to a still-Republican-led Senate and an intractable president, Democrats—and Representative Elijah Cummings, D-Maryland, now set to become the head of the House Oversight and Government Reform Committee—have the opportunity to flex some muscle on the issue. And that’s something Cummings has already engaged in, albeit without the power behind it to make more change than noise.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.